Selective Na v 1.1-activating toxins
To identify novel toxins that target nociceptors, we used calcium imaging to screen more than 100 spider, scorpion and centipede venoms for the ability to activate cultured somatosensory neurons. Venom from the tarantula Heteroscodra maculata (Fig. 1a ) robustly excited a subset of neurons from the trigeminal or dorsal root ganglia (DRG) of mice or rats. Venom fractionation yielded two active peptides, which were identified by matrix-assisted laser desorption/ionization-timeof-flight mass spectroscopy (MALDI-TOF MS) and Edman sequencing as inhibitor cystine knot (ICK) peptides with related sequences (Extended Data Fig. 1a ). We named these toxins δ-theraphotoxin-Hm1a (Hm1a) and δ-theraphotoxin-Hm1b (Hm1b). Application of synthetic Hm1a to rat DRG neurons likewise triggered calcium responses ( Fig. 1b) , validating Hm1a as an active venom component. All subsequent experiments were performed with synthetic Hm1a peptide unless otherwise stated.
Tetrodotoxin (TTX) blocked Hm1a-evoked calcium responses ( Fig. 1b ), suggesting that these responses involved Na v channels. Indeed, whole-cell patch-clamp recordings from trigeminal neurons showed that Hm1a robustly inhibited Na v current inactivation (Fig. 1c ). Among the Na v subtypes expressed by these neurons, only Na v 1.1, 1.6 and 1.7 are sensitive to TTX 21 , narrowing our search. We next tested ICA-121431, a small molecule inhibitor with selectivity for the Na v 1.1 and Na v 1.3 subtypes 22 (Extended Data Fig. 1b ), and found that it greatly diminished Hm1a-evoked calcium responses in both embryonic DRG and postnatal day (P)0 mouse trigeminal cultures ( Fig. 1d and Extended Data Fig. 1c, d ), suggesting that Na v 1.1 is the main target of Hm1a in somatosensory neurons. In contrast, ICA-121431 only partially blocked responses to SGTx1, an Hm1a-related peptide that shows little selectivity among Na v subtypes 23 and excites a larger cohort of sensory neurons compared to Hm1a (Extended Data Fig. 1c, d ).
To confirm that the toxin was selective for Na v 1.1 channels, we heterologously expressed Na v 1.1-Na v 1.8 α subunits in Xenopus oocytes. Hm1a potently inhibited inactivation of human (h)Na v 1.1 channels (half-maximum effective concentration (EC 50 ) = 38 ± 6 nM), but had Voltage-gated sodium (Na v ) channels initiate action potentials in most neurons, including primary afferent nerve fibres of the pain pathway. Local anaesthetics block pain through non-specific actions at all Na v channels, but the discovery of selective modulators would facilitate the analysis of individual subtypes of these channels and their contributions to chemical, mechanical, or thermal pain. Here we identify and characterize spider (Heteroscodra maculata) toxins that selectively activate the Na v 1.1 subtype, the role of which in nociception and pain has not been elucidated. We use these probes to show that Na v 1.1-expressing fibres are modality-specific nociceptors: their activation elicits robust pain behaviours without neurogenic inflammation and produces profound hypersensitivity to mechanical, but not thermal, stimuli. In the gut, high-threshold mechanosensitive fibres also express Na v 1.1 and show enhanced toxin sensitivity in a mouse model of irritable bowel syndrome. Together, these findings establish an unexpected role for Na v 1.1 channels in regulating the excitability of sensory nerve fibres that mediate mechanical pain.
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substantially weaker effects on hNa v 1.2 and hNa v 1.3, and no effect on hNa v 1.4-Na v 1.8 ( Fig. 1e and Extended Data Fig. 1e ). Similar results were obtained with native Hm1b (Extended Data Fig. 1f ). Na v 1.9 is not efficiently expressed in recombinant systems, but surrogate chimaeras (rat (r)K v 2.1 channels containing the S3b-S4 toxin-binding region from each of the four hNa v 1.9 domains) were also toxin-insensitive 24 (Extended Data Fig. 1g ).
Hm1b is a previously unknown toxin, but Hm1a was first identified as κ-theraphotoxin-Hm1a, a moderate-affinity blocker of K v 4.1 voltage-gated potassium (K v ) channels 25 . We found, however, that high concentrations (up to 5 μM) of synthetic Hm1a blocked only up to 20% of mouse (m)K v 4.1 current (Extended Data Fig. 1h ), and 1 μM native Hm1a exerted a saturating effect on Na v 1.1 but did not block mK v 4.1 (Extended Data Fig. 1h ). Moreover, in cultured sensory neurons, outward K + currents were unaffected by 500 nM Hm1a, suggesting that its main physiological target is Na v 1.1. This may explain why injection of Hm1a into the mouse brain elicits convulsions and rapid death 25 . Together, these results demonstrate that Hm1a activates a subset of sensory neurons by selectively targeting Na v 1.1 channels.
Analysis of Hm1a-responsive trigeminal neurons in whole-cell current clamp configuration showed toxin-evoked hyperexcitability ( Fig. 1f ). Hm1a did not alter the resting membrane potential (before Hm1a, V m = −55 ± 6 mV; after Hm1a, V m = −56 ± 6 mV), but it robustly enhanced spike frequency during a 20-pA current injection. Hm1a also significantly prolonged the action potential (by 28.3 ± 8.4%; from 6.5 to 8.6 ms), consistent with introduction of non-inactivating sodium current ( Fig. 1f ). We found that toxin responses were most robust in sensory neuron cultures derived from young (embryonic or newborn) mice or rats, probably reflecting a lower threshold for action potential firing in these cells or culture conditions. Consistent with this hypothesis, we found that sensitization of adult neurons with prostaglandin E2 (PGE 2 ) 26 before toxin exposure greatly enhanced the percentage of toxin-sensitive cells (Extended Data Fig. 1i ).
Selectivity depends on domain IV S1-S2 loop
Our data suggest that Hm1a inhibits both the speed and extent of fast inactivation ( Fig. 2a ), similar to the mechanism described for less selective peptide toxins that bind to the S3b-S4 voltage-sensor region of domain IV (DIV) 23 . To test whether Hm1a targets the same location, we transferred each of four S3b-S4 regions from hNa v 1.1 into the cognate location of the homo-tetrameric rK v 2.1 voltage-gated potassium Figure 1 | Hm1a selectively targets Na v 1.1 in sensory neurons. a, Togo Starburst tarantula, H. maculata. b, Average ratiometric calcium responses (to 340 versus 380 nM wavelength excitation) from Hm1a (500 nM)-sensitive embryonic rat DRG neurons with or without TTX (500 nM). Note persistence of toxin responses in the absence of TTX (top). c, Representative whole-cell patch clamp recording from Hm1a-sensitive P0 mouse trigeminal neuron. All (15/15) Hm1a responsive neurons displayed similar effect of toxin on sodium current inactivation. Currents elicited during repeated steps to −30 mV (V h = −90 mV; scale bar 1 nA, 5 ms). d, Left, average Hm1a-evoked calcium response in the presence of ICA-121431 (ICA; 500 nM) and after washout (n = 11; responses to Hm1a alone shown in grey; normalized to maximal response). Right, quantification of Hm1a-evoked responses (maximal change in 340/380 ratio) with or without ICA-121431 (n = 25). e, Currents from oocytes expressing hNa v channels in the absence (black) or presence (red) of 100 nM Hm1a elicited by repeated pulses (0.2-1 Hz) to −30 mV (Na v 1.1-1.7) or 0 mV (Na v 1.8) for 100 ms (V h = −90 mV; scale bar 100 nA, 25 ms). f, Top, representative current clamp recording from mouse trigeminal neuron in the absence (black) or presence (red) of Hm1a (500 nM). Bottom, quantification of action potentials (APs) elicited by a 1-s, 20-pA current injection before or after exposure to Hm1a (500 nM, n = 4) with representative action potentials shown on the right. Average action potential width increased in the presence of Hm1a by 28.3 ± 8.4% (P < 0.05, n = 4). *P < 0.05, ***P < 0.001, Student's t-test. Error bars represent mean ± s.e.m. 
Article reSeArcH channel, which is normally insensitive to the toxin (Extended Data Fig. 2a ). Transfer of just the DIV S3b-S4 region rendered rK v 2.1 sensitive to Hm1a, demonstrating that this segment is a primary determinant of toxin action ( Fig. 2b and Extended Data Fig. 2b ). However, this region is identical or highly conserved in hNa v 1.1, hNa v 1.2 and hNa v 1.3, and thus cannot fully account for toxin selectivity. To identify other functionally important regions, we constructed chimaeras between Na v 1.1 and Na v 1.4, which is completely insensitive to Hm1a. Replacement of the S3b-S4 region of rNa v 1.4 with that of hNa v 1.1 did not confer toxin sensitivity, whereas transfer of both S3b-S4 and the S1-S2 loop resulted in full toxin sensitivity ( Fig. 2c and Extended Data Fig. 2c-e ). These results indicate that both domains together determine toxin sensitivity and subtype selectivity, consistent with previous suggestions that S1-S2 contributes to toxin recognition sites on voltage sensors 27, 28 .
Na v 1.1 is found on myelinated Aδ fibres
Using in situ hybridization histochemistry, we found that Na v 1.1 transcripts were expressed primarily by medium-diameter sensory neurons (constituting 35% of all neurons within the DRG), most of which (>75%) belong to the myelinated (NF200-positive) cohort ( Fig. 3 ). In contrast, we observed limited (5-11%) overlap of Na v 1.1-positive cells with markers of small diameter, unmyelinated neurons, including the transient receptor potential cation channel subfamily V member 1 (TRPV1), calcitonin gene-related peptide (CGRP), tyrosine hydroxylase, and the lectin IB4. However, we did see substantial co-expression with the 5-HT 3 receptor, a marker of lightly myelinated Aδ neurons 29 (43% of Na v 1.1-positive cells expressed 5-HT 3 ). Finally, 22% of Na v 1.1positive cells also expressed the cold/menthol receptor TRPM8, which is found in both C and Aδ fibres 30 . From these findings, we conclude that Na v 1.1 is expressed primarily by myelinated neurons, including Aδ fibres, consistent with previous histological and transcriptome profiling data 7, 31 . We also characterized Hm1a-sensitive neurons for responses to other receptor-selective agonists (Extended Data Fig. 3b ), further confirming this conclusion. Notably, most (>85%) Na v 1.1positive cells also expressed Na v 1.7, suggesting that this population of myelinated neurons contributes to nociception (see below).
We next investigated the effect of Hm1a on mechanonociceptive Aδ fibres using the ex vivo skin-nerve preparation. We found that application of 1 μM Hm1a to cutaneous receptive fields significantly increased the firing rate in mechanonociceptive Aδ fibres in response to mechanical stimuli ( Fig. 3d ), confirming expression of functional Na v 1.1 channels in this afferent population. Previous studies found limited expression of TRPV1 in mechanonociceptive Aδ fibres 32 , consistent with our finding that there was limited overlap between Na v 1.1 and TRPV1 expression. Together, these functional data confirm our histological assignment of Na v 1.1 expression to myelinated Aδ fibres, and further suggest that Na v 1.1 participates in mechanical nociception.
Hm1a elicits pain and mechanical hypersensitivity
We investigated whether activation of Na v 1.1-expressing fibres produced pain behaviours. Injection of Hm1a (5 μM in 10 μl) into the mouse hind-paw elicited immediate and robust nocifensive responses (bouts of licking or biting of the injected paw) throughout the observation period (Fig. 4a ). Toxin injection also significantly increased Fos immunoreactivity in dorsal horn neurons of the superficial lamina ipsilateral to the injection, signifying functional engagement of nociceptors and their central connections ( Fig. 4b) . To exclude the possibility that this response depends on the small population of fibres that co-express TRPV1 and Na v 1.1, we ablated TRPV1-positive terminals by intrathecal (spinal) injection of capsaicin 33 ; Hm1a-evoked nocifensive behaviour persisted in these mice ( Fig. 4a ). Notably, Hm1a did not produce swelling or plasma extravasation of the injected paw, a neurogenic inflammatory response readily provoked by activation of peptidergic C-fibre nociceptors that include most TRPV1-expressing , and in situ histochemistry for TRPV1, Na v 1.7, or Na v 1.1 transcripts, as indicated. Arrows and asterisk indicate cells with overlapping and nonoverlapping signals, respectively. b, Size distribution for all DRG neurons (grey bars, 514 cells counted) or Na v 1.1-expressing cells (black bars, 324 cells counted). c, Quantification of overlap between histological markers (≥164 cells counted for each condition; 9-12 independent sections from ≥3 mice). d, Representative traces from mechanonociceptive Aδ fibres recorded in skin-nerve preparation show increased firing following application of Hm1a (1 μM) with quantification on the right. Hm1a markedly increased firing during all forces tested, achieving statistical significance at 50 and 100 mN (***P < 0.001 with two-way ANOVA, #P < 0.05 with Bonferonni post hoc test; n = 23, 23 and 18 fibres for vehicle and 13, 13 and 10 fibres for Hm1a at 15, 50 and 100 mN forces, respectively). Article reSeArcH neurons ( Fig. 4c ). These results further suggest that Hm1a elicits pain by activating a non-peptidergic subset of myelinated sensory fibres. Genetic or pharmacological elimination of TRPV1-expressing fibres greatly diminishes sensitivity to noxious heat, but does not perturb sensitivity to mechanical stimuli [33] [34] [35] . In light of the anatomical and physiological results described above, we tested whether Hm1a has differential effects on these modalities by monitoring responses to thermal and mechanical stimuli following intraplantar injection of toxin at a dose (500 nM in 10 μl) insufficient to elicit acute behaviour. Intraplantar injection of Hm1a did not alter sensitivity to heat, but produced robust sensitization to mechanical stimulation that was not dependent on TRPV1-expressing fibres ( Fig. 4d, e ). Equivalent mechanical sensitization was also observed following injection of native Hm1b peptide ( Fig. 4e ). Consistent with these behavioural observations, we found that all Hm1a-responsive adult DRG neurons displayed mechanically activated currents, except for those neurons that were also sensitive to capsaicin ( Fig. 4f ).
To confirm that Na v 1.1 is required for toxin-evoked behaviours, we crossed mice bearing a floxed Na v 1.1 allele 13 to a line expressing Cre recombinase under the control of the peripherin promoter, which is active in a large percentage of unmyelinated and myelinated sensory neurons during development 36 . Analysis of a peripherin-Cre × yellow fluorescent protein (YFP) reporter line showed that these mice expressed Cre recombinase in 46% of Na v 1.1-positive cells (Extended Data Fig. 4a, b) . Notably, elimination of Na v 1.1 from this subset of fibres significantly attenuated toxin-evoked behaviours, including both acute nocifensive responses and mechanical sensitization ( Fig. 4a, e ).
Robust activation of nociceptive pathways by nerve injury or inflammation can trigger both primary and secondary sensitization, the latter of which can manifest as mechanical or heat hypersensitivity contralateral to the insult 37, 38 . In fact, we found that unilateral injection of Hm1a produced robust and equivalent mechanical sensitization of both the injected and contralateral paws (Fig. 4e ). This contralateral sensitization was also modality-specific, as no change in heat sensitivity was observed ( Fig. 4d ). Importantly, Hm1a-mediated mechanical sensitivity was equivalently reduced in the ipsilateral and contralateral paws of Na v 1.1-peripherin Cre mice, demonstrating that the contralateral effects depend on Na v 1.1 (Fig. 4e ). As we did not observe signs of neurogenic inflammation, we investigated whether this phenotype resulted from Hm1a-mediated nerve injury. However, this seems unlikely because toxin injection failed to induce expression of ATF3, a marker of nerve damage 39 (Extended Data Fig. 4c ). Together, these observations demonstrate that direct activation of Na v 1.1-expressing fibres is sufficient to produce robust and modality-specific bilateral sensitization.
Na v 1.1 and irritable bowel syndrome
Chronic mechanical hypersensitivity underlies the development of abdominal pain in patients with irritable bowel syndrome (IBS) 40 . Given the apparent role of Na v 1.1 in mechanonociception, we investigated whether this channel is expressed by mechanically sensitive fibres of the gut, and, if so, whether it contributes to neuronal sensitization in a model of chronic visceral hypersensitivity (CVH) 41 . We examined mechanical responses in ex vivo gut-nerve preparations from healthy and CVH mice. In preparations from healthy mice, Hm1a increased mechanically evoked spiking in a subpopulation (40%) of high-threshold colonic afferents that constitute presumptive mechanonociceptors ( Fig. 5a and Extended Data Fig. 5a ). Correspondingly, ICA-121431 reduced mechanical responses in 50% of fibres examined and blocked Hm1a-induced sensitization ( Fig. 5a and Extended Data Fig. 5a ). Moreover, Hm1a significantly reduced the threshold for action potential firing in a subset (45%) of retrogradely d, Latency of paw withdrawal (WD) from noxious heat stimulus measured after intraplantar injection of vehicle or Hm1a (500 nM). e, Normalized mechanical response thresholds measured in paws ipsilateral (light grey) or contralateral (dark grey) to vehicle or toxin (500 nM) injection (n = 5 for wild type (WT) Veh., V1abl Hm1a and WT Hm1b; n = 7 for WT Hm1a; n = 9 for CKO Hm1a; **P < 0.01, ***P < 0.001, ****P < 0.0001). f, Mechanically evoked currents were observed from all adult mouse DRG neurons exhibiting sensitivity to Hm1a but not capsaicin (bottom), and not from those sensitive to both (top) (stimulus range 1-9 μm displacement). Kinetic properties of mechanically evoked currents in Hm1a responders were variable. Error bars represent mean ± s.e.m. P values based on unpaired two-tailed Student's t-test (b, c) or one-way ANOVA with post hoc Tukey's test (a, d, e ).
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traced colonic DRG neurons, as measured by whole-cell current clamp analysis ( Fig. 5b and Extended Data Fig. 5b) . These results demonstrate that a subset of high-threshold mechanosensitive colonic fibres express functional Na v 1.1 channels.
In colonic afferents from CVH mice, baseline mechanosensory responses were elevated compared to healthy controls (compare Fig. 5a and c). Application of Hm1a enhanced mechanically evoked spiking in a subset (36%) of CVH fibres beyond this already elevated level (Fig. 5c ). Notably, in the context of CVH (and in contrast to normal controls), toxin application markedly increased the electrical excitability of most (64%) retrogradely traced colonic DRG neurons (Fig. 5d ), suggesting that Na v 1.1 channels were functionally upregulated. Furthermore, ICA-121431 reduced mechanosensory responses in most (70%) CVH sensitized fibres to levels resembling those of baseline controls (compare Fig. 5a and c) and blocked the sensitizing effects of Hm1a (Fig. 5c ). Together, these results support the idea that Na v 1.1 is involved in mechanical hypersensitivity in IBS.
Concluding remarks
The development of Na v channel subtype-selective ligands is an important but challenging goal. Our results identify a site within the DIV S1-S2 loop that enhances subtype selectivity, providing a potential strategy for designing other subtype-specific gating modifiers. Moreover, toxins such as Hm1a and Hm1b, which alter inactivation, may be of particular utility in boosting Na v channel activity where partial loss-of-function has been linked to developmental or neurodegenerative disorders, such as autism, Alzheimer disease and Dravet syndrome 14, 15, 42 . Analysis of toxin-channel interactions, including the multi-site nature of this pharmacophore, may shed new light on strategies for developing a broader class of molecules with similar selectivity and functional profiles.
The critical role of Na v 1.1 in the brain may have prevented its prior recognition as a contributor to peripheral pain signalling. Our results now unambiguously implicate Na v 1.1 and Na v 1.1-expressing myelinated afferents in nociception. Activation or sensitization of these fibres is sufficient to elicit robust acute pain and mechanical allodynia without triggering neurogenic inflammation, distinguishing these fibres from well-characterized C-nociceptors. Previous studies have implicated myelinated Aδ fibres in mechanonociception 43, 44 , and Na v 1.1 now provides an important new marker with which to more precisely identify the contribution of these fibres to acute and chronic pain.
Our experiments in CVH mice suggest that pharmacological blockade of Na v 1.1 represents a novel therapeutic strategy for diminishing the chronic pain in IBS, and perhaps other pain conditions associated with mechanical sensitization, including migraine headache. Although Na v 1.1 activity in the brain may underlie aura in patients with type 3 familial hemiplegic migraine (FHM3) 17 , our results suggest that these gain-of-function mutations may also produce migraine pain through actions of Na v 1.1 in mechanical nociceptors. In fact, anticonvulsants that target Na v channels, including Na v 1.1, have been shown to reduce migraine attacks in some individuals 45, 46 . Moreover, rufinamide, an anticonvulsant that was recently shown to inhibit Na v 1.1 (ref. 47) , has also been reported to diminish nerve-injuryevoked mechanical allodynia 48 . Our findings provide a mechanistic rationale for these actions, and motivate further analysis of the roles of Na v 1.1 and Na v 1.1-expressing nociceptors in acute and persistent pain.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
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MethOdS Venom collection and screening. Venom from spiders, scorpions and centipedes was collected by mild electrical stimulation of the chelicerae, telson or forcipules, respectively. Venom samples were then lyophilized and kept frozen until use. Approximately 100 venoms were tested by ratiometric calcium imaging using a standard inverted microscope setup. Responses to high extracellular potassium (150 mM), capsaicin (1 μM), or previously characterized venoms or purified toxins 19 were used to validate the health and robustness of sensory neuron cultures used in screening assays. Responses were digitized and analysed using MetaMorph software (Molecular Devices). Venom-evoked responses that were stimulus-locked, visually detectable above background, and restricted to neurons (that is, did not cause calcium entry into glia or fibroblasts) were selected for further analysis. Pharmacological analysis was used to narrow down potential targets and crude venoms or purified fractions were subsequently tested on cloned candidate channels. Candidates were taken forward based on the robustness of the response and evidence for selectivity at novel targets. See Supplementary Information for a summary of venoms that produced no detectable or specific response in our hands. Hm1a/b isolation. Venom from H. maculata (1 mg dried) was fractionated on a C18 reversed-phase (RP) high-performance liquid chromatography (HPLC) column (Jupiter 250 × 4.6 mm, 5 mm; Phenomenex) on a Shimadzu Prominence HPLC system. The following linear gradient of solvent B (90% acetonitrile (MeCN), 0.1% formic acid in water) in solvent A (0.1% formic acid in water) was used at a flow rate of 1 ml min −1 : 5% B for 5 min, then 5-20% B for 5 min followed by 20-40% B over 40 min. Absorbance was measured at 214 nM and 280 nM and collected fractions were lyophilized before storage at −20 °C. Mass spectrometry. Peptide masses were determined by MALDI-TOF MS using a 4700 Proteomics Bioanalyzer model (Applied Biosystems). Peptides were dissolved in water and mixed 1:1 (v/v) with α-cyano-4-hydroxycinnamic acid matrix (7 mg ml −1 in 50% MeCN, 5% formic acid) and mass spectra acquired in positive reflector mode. All reported masses are for the monoisotopic M+H + ions. Sequence determination. N-terminal sequencing was performed by the Australian Proteome Analysis Facility. In brief, Hm1a (600 pmol) and Hm1b (250 pmol) were reconstituted and reduced by addition of DTT (25 mM) followed by incubation at 56 °C for 0.5 h. The samples were then alkylated using iodoacetamide (55 mM) at room temperature for 0.5 h and purified by RP-HPLC using a Zorbax 300SB-C18 column (3 × 150 mm). The target peaks of interest were identified, collected and then reduced to minimal volume under vacuum. The entire sample was loaded onto a precycled, Biobrene-treated disc and subjected to 37 (Hm1a) or 42 (Hm1b) cycles of Edman N-terminal sequencing. Automated Edman degradation was carried out using an Applied Biosystems 494 Procise Protein Sequencing System.
Edman degradation of Hm1a yielded ECRYLFGGCSSTSDCCKHLSCRSDW KYCAWDGTF as the sequence, which has a calculated monoisotopic mass (for the M+H + ion) of 3,908.58 Da. This is 86.97 Da short of the monoisotopic mass of Hm1a of 3,995.55 Da. Hence, we concluded that a serine residue (87 Da) was missing from the C-terminal end of Hm1a to give a complete sequence of ECRYLFGGCSSTSDCCKHLSCRSDWKYCAWDGTFS. The complete sequence has a calculated monoisotopic mass (for the M+H + ion) of 3,995.61 Da, which is only 0.06 Da different from the mass that was measured for the native Hm1a.
Edman degradation of Hm1b yielded ECRYLFGGCKTTADCCKHLGCRTDLY YCAWDGT as the sequence, which has a calculated monoisotopic mass (for the M+H + ion) of 3,745.6 Da. This is 147 Da short of the monoisotopic mass of Hm1a of 3,892.60 Da. We therefore concluded that an amidated phenylalanine was missing from the C-terminal end of Hm1b to give a complete sequence of ECRYLFGGCKTTADCCKHLGCRTDLYYCAWDGTF-NH 2 . To confirm that the C terminus of Hm1b is amidated, we digested native Hm1b with carboxypeptidase Y (CPY) and monitored the reaction by MALDI-TOF MS to identify the mass of the C-terminal residue as described previously 50 . Native Hm1b (5 μl of 800 ng μl −1 ) in 100 mM ammonium acetate, pH 5.5, was incubated with 2 ng μl −1 CPY at 37 °C for 20 min. The reaction was monitored by removing 0.4 μl at 0, 1, 5, 10 and 20 min and spotting it on a MALDI plate with equal volume of 7 mg ml −1 α-cyano-4-hydroxy cinnamic acid in 60% (v/v) MeCN, 5% formic acid (FA). Dried spots were washed with 10 μl 1% FA and allowed to dry before they were analysed by MALDI-TOF MS on a 4700 Proteomics Bioanalyser (Applied Biosciences), acquiring spectra in reflector positive mode. The first CPY-mediated cleavage yielded a mass difference of 146 Da, which corresponds to an amidated phenylanine residue. Thus, the complete sequence has a calculated monoisotopic mass (for the M+H + ion) of 3892.64 Da, matching native Hm1b. Hm1a synthesis. Solvents for RP-HPLC consisted of 0.05% TFA/H 2 O (solvent A) and 90% MeCN/0.043% trifluoroacetic acid (TFA)/H 2 O (solvent B). Analytical HPLC was performed on a Shimadzu LC20AT system using a Thermo Hypersil GOLD 2.1 × 100 mm C18 column heated at 40 °C with a flow rate of 0.3 ml min −1 . A gradient of 10 to 55% B over 30 min was used, with detection at 214 nm.
Preparative HPLC was performed on a Vydac 218TP1022 column running at a flow rate of 16 ml min −1 using a gradient of 10 to 50% solvent B over 40 min. Mass spectrometry was performed on an API2000 (ABI Sciex) mass spectrometer in positive ion mode. All reagents were obtained commercially and were used without further purification.
Hm1a was synthesized using regioselective disulfide-bond formation [51] [52] [53] . The peptide was assembled on a 0.1-mmol scale using a Symphony (Protein Technologies Inc.) automated peptide synthesizer and a H-Ser(tBu)-2-ClTrt (loading 0.69 mmol g −1 ) polystyrene resin. Couplings were performed in dimethylformamide (DMF) using 5 equivalents of Fmoc-amino acid/(2-(1H-benzotriazol-1-yl)-1,1,3,3tetramethyluronium hexafluorophosphate (HBTU)/N,N-diisopropylethylamine (DIEA) (1:1:1) relative to resin loading for 2 × 20 min. Fmoc deprotection was achieved using 30% piperidine/DMF (1 × 1.5 min, then 1 × 4 min). Non-cysteine amino acid side-chains were protected as Asp(OtBu), Arg(Pbf), Glu(OtBu), His(Trt), Lys(Boc), Ser(tBu), Thr(tBu), Trp(Boc) and Tyr(tBu). The cysteine side chains were protected as Cys2,Cys16(Meb), Cys9,Cys21(Dpm), and Cys15,Cys28(Trt). Cleavage from the resin was achieved by treatment with 10% acetic acid/10% trifluoroethanol (TFE)/dichloromethane (DCM) at room temperature for 1 h. The product was precipitated and washed with n-hexane then lyophilized from 1,4-dioxane/MeCN/H 2 O.
The first disulfide bond (Cys15-Cys28) was formed by dissolving the crude product in in HFIP (5 ml) and adding it dropwise to a stirred solution of I 2 (4 equivalents) in 10% 1,1,1,3 The remaining side-chain-protecting groups (except Cys(Meb)) were removed by treatment with 95% TFA/2.5% triisopropylsilane (TIPS)/2.5% H 2 O at room temperature for 2 h. After most of the cleavage solution was evaporated under a stream of N 2 , the product was precipitated and washed with cold 1Δ7 construct contains seven point mutations in the outer vestibule that render the channel sensitive to agitoxin-2, a pore-blocking scorpion toxin 56 . cRNA of all constructs was synthesized using T3 or T7 polymerase (mMessage mMachine kit, Life Technologies) after linearizing the fully-sequenced DNA with appropriate restriction enzymes. Xenopus oocytes. Channels and chimaeras were expressed in Xenopus laevis oocytes (animals acquired from Xenopus one) that were incubated at 17 °C in Barth's medium (88 mM NaCl, 1 mM KCl, 0.33 mM Ca(NO 3 ) 2 , 0.41 mM CaCl 2 , 0.82 mM MgSO 4 , 2.4 mM NaHCO 3 , 5 mM HEPES, and 0.1 mg ml −1 gentamycin; pH 7.6 with NaOH) for 1-4 days after cRNA injection, and then were studied using two-electrode voltage-clamp recording techniques (OC-725C; Warner Instruments or GeneClamp 500B; Axon Instruments) with a 150-μl recording chamber or a small volume (<20 μl) oocyte perfusion chamber (AutoMate Scientific). Data were filtered at 4 kHz and digitized at 20 kHz using pClamp 10
Article reSeArcH software (Molecular Devices). Microelectrode resistances were 0.5-1 MΩ when filled with 3 M KCl. For K v 2.1 and K v 2.1 chimaera experiments, the external recording solution contained (in mM): 50 KCl, 50 NaCl, 5 HEPES, 1 MgCl 2 and 0.3 CaCl 2 , pH 7.6 with NaOH. For Na v and K v 4.1 experiments, the external recording solution contained (in mM): 100 NaCl, 5 HEPES, 1 MgCl 2 and 1.8 CaCl 2 , pH 7.6 with NaOH. For Na v channel experiments, the external recording solution contained (in mM): 100 NaCl, 5 HEPES, 1 MgCl 2 and 1.8 CaCl 2 , pH 7.6 with NaOH. All experiments were performed at room temperature (~22 °C) and toxin samples were diluted in recording solution with 0.1% BSA. Leak and background conductance, identified by blocking the channel with agitoxin-2 or TTX, were subtracted for K v or Na v channel currents, respectively. Voltage-activation relationships were obtained by measuring tail currents for K v channels, or by monitoring steady-state currents and calculating conductance for Na v channels. Occupancy of closed or resting channels by toxins was examined using negative holding voltages where open probability was low, and the fraction of unbound channels was estimated using depolarizations that are too weak to open toxin-bound channels. After addition of toxin to the recording chamber, equilibration between toxin and channel was monitored using weak depolarizations elicited at 5-10-s intervals. For all channels, voltage-activation relationships were recorded in the absence and presence of toxin. Off-line data analysis was performed using Clampfit 10 (Molecular Devices) and Origin 7.5 (Originlab).
Multiple protocols were used to probe the biophysical characteristics of the Na v channels and chimaeras studied. To determine conductance-voltage and steady-state inactivation relationships, oocytes expressing Na v channels were held at −90 mV and depolarized in 5-mV steps from −90 mV to 5 mV for 50 ms, immediately followed by a step to −15 mV to elicit the maximum available current and after 50 ms, returned to the −90 mV holding potential. Peak current generated during the incremental portion of the protocol was used to calculate the conductance-voltage relationship while the peak current during the −15 mV step as a function of the earlier voltage step was used to determine the steady-state inactivation relationship. The time constant of fast inactivation was determined by fitting single exponential curves to the −15 mV step of the aforementioned protocol. Boltzmann curves were fitted in Clampfit 10 (Molecular Devices) and statistics calculated with Excel or the R statistical package (Student's t-test). Cultured neurons. Whole-cell patch clamp of cultured mouse trigeminal neurons was performed as described 57 . Buffer solution contained (in mM) 150 NaCl, 2.8 KCl, 1 MgSO 4 , 10 HEPES, pH 7.4 with NaOH and was perfused with or without toxins/drugs using a SmartSquirt Micro-Perfusion system (AutoMate). For colonic DRG, whole-cell recordings were made from fluorescently labelled thoracolumbar (T10-L1) colonic DRG neurons 20-48 h after plating, using fire-polished glass electrodes with a resistance of 2-5 MΩ. All recordings were performed at room temperature (20-22 °C). Signals were amplified by using an Axopatch 200A amplifier, digitized with a Digidata 1322A and recorded using pCLAMP 9 software (Molecular Devices). For all DRG neurons the holding potential was −70 mV. In current clamp mode a series of depolarizing pulses (500 ms, 10 pA step) were applied from holding potential (−70 mV) and the rheobase (amount of current (pA) required for action potential generation) determined. The number of action potentials at 2 × rheobase was also determined. Depolarizing pulses were tested in normal external bath solution and following the addition of Hm1a (100 nM). Control solutions and Hm1a were applied with a gravity-driven multi-barrel perfusion system positioned within 1 mm of the neuron under investigation. Intracellular solutions contained (in mM): 135 KCl; 2 MgCl 2 ; 2 MgATP; 5 EGTA-Na; 10 HEPES-Na; adjusted to pH 7.4. Extracellular solutions contained (in mM): 140 NaCl; 4 KCl; 2 MgCl 2 ; 2 CaCl 2 ; 10 HEPES-Na; 5 glucose; adjusted to pH 7.4. Skin-nerve recordings. To assess primary afferent activity in response to the Hm1a spider toxin, we used the ex vivo skin-nerve preparation, as previously described 58 . Briefly, animals were lightly anaesthetized with inhaled isoflurane and then killed by cervical dislocation. The hair on the lower extremities was shaved, and the hairy skin of the hindpaw was then quickly dissected along with its innervating saphenous nerve. The skin and nerve were then placed in a recording chamber filled with warmed (32 °C), oxygenated buffer consisting of (in mM): 123 NaCl, 3.5 KCl, 2.0 CaCl 2 , 1.7 NaH 2 PO 4 , 0.7 MgSO 4 , 9.5 sodium gluconate, 5.5 glucose, 7.5 sucrose and 10 HEPES titrated to a pH of 7.45 ± 0.05.
The saphenous nerve was then threaded into a mineral oil-filled chamber, teased apart atop an elevated mirror plate, and placed on an extracellular recording electrode. Single-unit receptive fields were then identified with a mechanical search stimulus using a blunt glass probe. Aδ afferents were identified based on a conduction velocity between 1.2 and 10 m s −1 , and were subtyped into A-mechanonociceptors based on their slow adaptation to a mechanical stimulus 59 .
After locating an A-mechanonociceptor fibre, to determine the threshold force for action potential generation, the receptive field was stimulated with calibrated Von Frey filaments. A metal moat (inner diameter: 4.7 mm) was then placed over the centre of the receptive field to isolate it from the surrounding buffer. Buffer within the moat was then evacuated and replaced with a buffer containing either 1 μM Hm1a or vehicle (buffer). Receptive fields were incubated with toxin or buffer for 2-5 min. A custom-built, feedback-controlled mechanical stimulator was then placed within the moat and the receptive field was mechanically stimulated with a series of increasing forces (15 mN, 50 mN and 100 mN) for 10 s each. To avoid sensitization/desensitization, a rest period of 1 min was introduced between stimulations.
Data were digitized using a PowerLab A/D converter and recorded using LabChart software and Spike Histogram extension (AD Instruments). All skinnerve data were recorded and analysed with the experimenter blinded to whether toxin or vehicle was used. Recordings were included in the final data set only if the firing of the fibre was clearly distinguishable from both background noise and any other fibres firing during stimulation. Gut-nerve recordings. Ex vivo single-unit extracellular recordings of action potential discharge were made from splanchnic colonic afferents. Recordings were made from healthy or CVH mice using standard protocols [60] [61] [62] . Baseline mechanosensitivity was determined in response to application of a 2-g Von Frey hair probe to the afferent receptive field for 3 s. This process was repeated 3-4 times, separated each time by 10 s. Mechanosensitivity was then re-tested after the application of Hm1a (100 nM) or the Na v 1.1 blocker ICA-121432 (500 nM) or a combination of both ICA-121432 (500 nM) and Hm1a (100 nM). Instantaneous frequency is defined as the inverse of the time interval between an action potential and the previous action potential. After application of Hm1a, significant increases (P < 0.05) in mechanically evoked firing were seen overall in both healthy and CVH fibres. However, in both conditions we clearly recorded Hm1a-responsive and Hm1anon-responsive neurons. We therefore binned fibres by responsiveness and present these data separately for clarity ( Fig. 5 and Extended Data Fig. 5 ). Group data are presented as spikes per second and are expressed as mean ± s.e.m. Animal use, husbandry and genotyping. Mice were bred and housed in accordance with UCSF Institutional Animal Care Committee (IACUC) guidelines. Animals were housed in groups of 2-5 with constant access to food and water. Floxed Scn1a mice 13 were provided by W. Catterall. Floxed mice were bred to peripherin-Cre (Per-Cre) mice 36 to produce Scn1a F/F × Per-Cre conditional knockout mice. Na v 1.1 floxed alleles were detected using primers previously described 13 and Per-Cre expression was detected using the following primers to Cre recombinase: Cre_F: TAGCGTTCGAACGCACTGATTTCG; Cre_R: CGCCGTAAATCAATCGATGAGTTG.
Somatic behavioural experiments were approved by UCSF IACUC and were in accordance with the National Institutes of Health (NIH) Guide of the Care and Use of Laboratory Animals and the recommendation of the International Association for the Study of Pain. Animals used in skin-nerve recordings were naive C57BL/6 male mice (n = 10), aged 6-16 weeks. Mice were housed on a 14:10 h light:dark cycle with ad libitum access to food and water in a climate-controlled room. All protocols were approved by the Institutional Animal Care and Use Committee at the Medical College of Wisconsin. Animals used in colonic afferent and colonic DRG neuron studies were male C57BL/6J mice. The Animal Ethics Committees of The University of Adelaide and the South Australian Health and Medical Research Institute (SAHMRI) approved experiments involving animals. Sensory neuron culture and calcium imaging. Trigeminal ganglia were dissected from newborn (P0-P3) Sprague-Dawley rats or C57BL/6 mice and cultured for >12 h before calcium imaging or electrophysiological recording. Embryonic DRG cultures were provided by J. Chan 63 . Embryonic cultures were maintained as described and calcium imaging experiments were performed 1-10 d after primary cultures were established. Primary cells were plated onto cover slips coated with poly-l-lysine (Sigma) and laminin (Invitrogen. 10 μg ml −1 ). Cells were loaded for calcium imaging with Fura-2-AM (Molecular Probes) for >1 h. Buffer solution ((in mM), 150 NaCl, 2.8 KCl, 1 MgSO4, 10 HEPES, pH 7.4 with NaOH) was perfused with or without toxins/drugs using a SmartSquirt Micro-Perfusion system (AutoMate). In situ hybridization and immunohistochemistry. In situ hybridization (ISH) was performed using ViewRNA ISH Tissue 2-plex or 1-plex Assay Kits (Affymetrix). Target mRNA signals appear as puncta in bright field or fluorescent microscopy. Eight-to-twelve-week-old mice were deeply anaesthetized with pentobarbital then transcardially perfused with 10 ml PBS followed by 10 ml 10% neutral buffered formalin (NBF). DRGs were dissected, post-fixed in 10% NBF at 4 °C overnight, cryoprotected in PBS with 30% (w/v) sucrose overnight at 4 °C, then embedded in OCT compound at −20 °C. Tissue was sectioned at 12 μm, thaw-captured on Diamond White Glass slides (Globe Scientific), and stored at −20 °C until use. Slides were used within 2 weeks of processing to produce optimal signals.
ViewRNA ISH Tissue 2-plex assay was performed with frozen tissue modifications as indicated by the manufacturer including the endogenous alkaline phosphatase inactivation by incubation in H 2 O with 0.1 M HCl and 300 mM NaCl. The haematoxylin and eosin counterstaining procedure was omitted. Images were
